# Adalimumab

## Humira inj 40mg/0.4mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IHUM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 適應症     | Monotherapy or in combination with methotrexate or other DMARDs for reducing of the signs & symptoms & to inhibit the progression of structural damage in adult patients with moderately to severely active RA. Monotherapy or in combination with other DMARDs for reducing the signs & symptoms of active arthritis in patients with psoriatic arthritis. Reduction of signs & symptoms in patients with active ankylosing spondylitis. Reduction of signs & symptoms & inducing & maintaining clinical remission in adult patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy or if they have also lost response to or are intolerant to infliximab. Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy & when other systemic therapies are medically less appropriate. Reduction of the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients 13-17 years. |
| 用法用量   | SC, Adult Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis 40 mg every other week. If not taking concomitantly with methotrexate, increasing the dosing frequency to 40 mg weekly may derive additional benefit. Crohn's disease, ulcerative colitis 160 mg initially at day 1 (as four 40-mg in 1 day or as two 40-mg/day for 2 consecutive days), followed by 80 mg 2 weeks later (day 15). Another 2 weeks later (day 29) begin a maintenance dose of 40 mg every other week. Patients who experience decrease in their response may benefit from an increase in dose intensity to 40 mg every week. Plaque psoriasis Initially 80 mg, followed by 40 mg given every other week starting 1 week after the initial dose.                                                                                                                                                                                                                                                                                         |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 禁忌       | Known hypersensitivity to adalimumab or any of the excipients of Humira.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 副作用     | Resp tract infections, leucopenia, anemia, increased lipids, headache, abdominal pain, nausea & vomiting, elevated liver enzymes, rash, musculoskeletal pain, inj site reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 孕期建議   | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

